Literature DB >> 17292327

DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.

Tai Young Kim1, Jung Weon Lee, Hwang-Phill Kim, Hyun-Soon Jong, Tae-You Kim, Mira Jung, Yung-Jue Bang.   

Abstract

DLC-1 (deleted in liver cancer-1) is a tumor suppressor gene for hepatocellular carcinoma and other cancers. To characterize its functions, we constructed recombinant adenovirus encoding the wild-type DLC-1 and examined its effects on behaviors of a hepatocellular carcinoma cell line (SNU-368), which does not express DLC-1. Here, we found that restoration of DLC-1 expression in the SNU-368 cells caused an inhibition of cell proliferation with an increase of a subG1 population. Furthermore, DLC-1 overexpression induced disassembly of stress fibers and extensive membrane protrusions around cells on laminin-1. DLC-1 overexpression also inhibited cell migration and dephosphorylated focal adhesion proteins such as focal adhesion kinase (FAK), Cas (p130Cas; Crk-associated substrate), and paxillin. These observations suggest that DLC-1 plays important roles in signal transduction pathway regulating cell proliferation, cell morphology, and cell migration by affecting Rho family GTPases and focal adhesion proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292327     DOI: 10.1016/j.bbrc.2007.01.121

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism.

Authors:  Xuyu Yang; Nicholas C Popescu; Drazen B Zimonjic
Journal:  Cancer Res       Date:  2011-03-03       Impact factor: 12.701

2.  Effect of FAK, DLC-1 gene expression on OVCAR-3 proliferation.

Authors:  Huina Liu; Huirong Shi; Yibin Hao; Guoqiang Zhao; Xiaofeng Yang; Yali Wang; Mei Li; Min Liu
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

Review 3.  Feeling Things Out: Bidirectional Signaling of the Cell-ECM Interface, Implications in the Mechanobiology of Cell Spreading, Migration, Proliferation, and Differentiation.

Authors:  Andrew E Miller; Ping Hu; Thomas H Barker
Journal:  Adv Healthc Mater       Date:  2020-02-09       Impact factor: 9.933

4.  Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis.

Authors:  Tai On Yau; Thomas Ho Yin Leung; Sandra Lam; Oi Fung Cheung; Edmund Kwok Kwan Tung; Pek Lan Khong; Amy Lam; Sookja Chung; Irene Oi Lin Ng
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

5.  Detection and Clinical Significance of DLC1 Gene Methylation in Serum DNA from Colorectal Cancer Patients.

Authors:  Ping-Ping Wu; Ji-Hong Zou; Ri-Ning Tang; Yao Yao; Cheng-Zhong You
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

6.  DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.

Authors:  Xiaoling Zhou; Drazen B Zimonjic; Sang-Won Park; Xu-Yu Yang; Marian E Durkin; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

Review 7.  Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility.

Authors:  T Y Kim; D Vigil; C J Der; R L Juliano
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

8.  Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.

Authors:  Wenzhen Zhu; Long Ma; Bingwu Yang; Zhaodi Zheng; Rongfei Chai; Tingting Liu; Zhaojun Liu; Taiyu Song; Fenglin Li; Guorong Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-03-02       Impact factor: 2.416

Review 9.  Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.

Authors:  Nicholas C Popescu; Steve Goodison
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

10.  Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.

Authors:  Lo-Kong Chan; Frankie Chi Fat Ko; Irene Oi-Lin Ng; Judy Wai Ping Yam
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.